Literature DB >> 8655926

Paroxystic hypertension in a long-term hemodialyzed patient. Successful adrenalectomy for a dopamine-producing pheochromocytoma.

A Ferrante1, R Bellantone, A Barbarino, S Corsello, C A Rota, R Ranieri, L Sollazzi, M Sciarra, F Meo, G Luciani.   

Abstract

Pheochromocytoma (Pheo) is an uncommon neoplasm producing blood pressure troubles and it may be undiagnosed in chronic dialyzed patients in whom hypertension is a common finding. The symptoms in Pheo syndrome depends on the prevalent catecholamine released, the most common being epinephrine (E) and norepinephrine (NE). Recently, a particular clinical picture has been described for dopamine (DA)-producing Pheos, in whom a normo-hypotensive status is more often observed. The authors report a case of mainly dopamine-producing Pheo in a long-term dialyzed patient, successfully treated with adrenalectomy. The main steps in diagnosis and preoperative management are described and debated also in view of the particular background produced by the end-stage renal failure. The common imaging techniques adopted for adrenal medullary neoplasms (US, CT, MIBG scintiscan) confirmed to be decisive for diagnosis; HPLC assay of plasma catecholamines is the only biochemical test available in these patients although its significance is questionable due to the poor knowledge of catecholamine metabolism in chronic renal failure. The clinical findings observed in this case seem in disagreement with those already reported in DA producing Pheos. Pheo in hemodialyzed patients is a rare event and it may be hidden by other more common causes of hypertension. However, more awareness from the medical staff allows to diagnose the neoplasm correctly by the currently available methods and to plan a safe surgical therapy also in high-risk patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8655926     DOI: 10.1007/BF03349785

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  34 in total

1.  Pheochromocytoma: postoperative shock and blood volume.

Authors:  S BRUNJES; V J JOHNS; M G CRANE
Journal:  N Engl J Med       Date:  1960-02-25       Impact factor: 91.245

Review 2.  Preoperative and surgical management of pheochromocytoma.

Authors:  M J Malone; J A Libertino; N P Tsapatsaris; B O Woods
Journal:  Urol Clin North Am       Date:  1989-08       Impact factor: 2.241

3.  [Anesthesia for a patient with pheochromocytoma associated with chronic renal failure].

Authors:  T Yamamoto; K Iizima; T Mizuguchi
Journal:  Masui       Date:  1989-06

Review 4.  Adrenal imaging.

Authors:  H A Mitty; B A Cohen
Journal:  Urol Clin North Am       Date:  1985-11       Impact factor: 2.241

5.  Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.

Authors:  B Shapiro; J E Copp; J C Sisson; P L Eyre; J Wallis; W H Beierwaltes
Journal:  J Nucl Med       Date:  1985-06       Impact factor: 10.057

6.  Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion.

Authors:  C Proye; P Fossati; P Fontaine; J Lefebvre; M Decoulx; J L Wemeau; D Dewailly; E Rwamasirabo; P Cecat
Journal:  Surgery       Date:  1986-12       Impact factor: 3.982

7.  Haemodynamics in patients with phaeochromocytoma.

Authors:  J A Levenson; M E Safar; G M London; A C Simon
Journal:  Clin Sci (Lond)       Date:  1980-05       Impact factor: 6.124

8.  MR imaging of the adrenals: correlation with computed tomography.

Authors:  T H Falke; L te Strake; M I Shaff; M P Sandler; M V Kulkarni; C L Partain; A C Nieuwenhuizen-Kruseman; A E James
Journal:  J Comput Assist Tomogr       Date:  1986 Mar-Apr       Impact factor: 1.826

9.  Pheochromocytoma: current status and changing trends.

Authors:  J A van Heerden; S G Sheps; B Hamberger; P F Sheedy; J G Poston; W H ReMine
Journal:  Surgery       Date:  1982-04       Impact factor: 3.982

10.  The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma.

Authors:  Y Ito; Y Fujimoto; T Obara
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.